News

Researchers have engineered an enzyme to produce synthetic genetic material, advancing the discovery of new therapeutics for cancer and autoimmune, metabolic and infectious diseases.

Three patients are in “safe, deep remission” after receiving a CRISPR-Cas9-modified cell therapy for autoimmune disease treatment, according to a new published study in Cell.

Researchers have created the first systematic map illustrating how specific food molecules interact with unique gut bacteria. This study highlights the variability in dietary responses among individuals.

A collaborative study between UK and Italian researchers investigates the biological mechanisms of major depressive disorder (MDD), focusing on the immune system's involvement. The research highlights gene expression profiles linked to inflammation.

Researchers identified a new mechanism in the DNA damage response involving the long non-coding RNA NEAT1. Increased NEAT1 levels and methylation enhance the recognition of DNA damage.

One of the largest and most diverse studies to date on genetic factors related to epilepsy has revealed potential new treatment targets.

A study has identified living microbes in 2-billion-year-old rock from the Bushveld Igneous Complex in South Africa. This discovery, confirmed through advanced imaging techniques, could enhance understanding of early life on Earth.

Frequent use of doxycycline – a post-exposure prophylaxis for STIs – increases antibiotic resistance in the gut microbiome.

Researchers studied Arabidopsis thaliana to understand how plants maintain chromosome stability when the critical molecule DDM1 is absent. They discovered that transposons trigger RNA interference to restore centromere function.

Single-cell RNA-seq datasets could lead to privacy violations through "linking attacks," where hackers can identify individuals' genetic and phenotypic information. This study highlights the need for stricter consent policies.